B
Evidence Grade B
Graded
under review
Safe to Cite
Current
80%
80% -- share of patient groups receiving pharma funding for US patient advocacy groups (2026)
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
80%
Unit
Percentage
Data Vintage
2026
Entity
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
50
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
New York Times
Primary
Tier C
http://axisoflogic.com/artman/publish/printer_76265.shtml ↗
Source Article
print:Proof That the Pharma Business Model Actually Wants People Sick
Original Research
New York Times
· Original study ↗
Methodology
Reported by the New York Times per the article; original methodology not stated
Methodology documented
Segmentation
Industryhealthcare
Cite this stat
Plain Text
US patient advocacy groups: 80% share of patient groups receiving pharma funding. Source: New York Times (2026). Via Lighthouse Intelligence -- https://lighthousedata.io/data/pharma-funded-patient-groups-80-percent
HTML Embed
<blockquote cite="https://lighthousedata.io/data/pharma-funded-patient-groups-80-percent" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>80%</strong> -- share of patient groups receiving pharma funding for US patient advocacy groups<br><small>Source: New York Times (2026) · <a href="https://lighthousedata.io/data/pharma-funded-patient-groups-80-percent" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.